 sell
- There is no classification
contact
- Contact：伍小姐
- Phone：010-52801387
- Email：geneplus2015@163.com
- fax：010-52801387
link |
|
| Company Name： |
Beijing Jiyinga Technology Co., Ltd. |
Company type： |
企业单位 (服务商) |
| area： |
Beijing |
Company Size： |
100-499人 |
| Registered capital： |
5000000人民币 |
Registration year： |
2015 |
| Data certification： |
 |
| security deposit： |
Already paid ￥0.00 元 |
| Business model： |
服务商 |
| Business Scope： |
Genetic Testing for Accurate Oncology Drugs (Gene+OncoD): It is a multi-gene testing service launched by Gene+OncoD for tumor patients. The test is based on the latest generation of high-throughput sequencing technology and can be obtained by testing blood, tumor frozen tissue or paraffin sections. Comprehensive genetic mutation and tumor molecular classification information assists clinicians in formulating personalized medication plans to achieve precise treatment results. A. Help your doctor choose the drug that is most likely to be effective for you; B. Help your doctor avoid choosing the drug that is most likely to be ineffective for you or have serious side effects; C. Help your doctor determine the most appropriate time to use or discontinue medication. Precise tumor genetic risk test (Gene+OncoH): It is a genetic test developed by Gene+OncoH based on high-throughput sequencing technology to accurately predict tumor genetic risk. |
| Sales Products： |
肿瘤检测,肿瘤基因检测,基因检测,精准医疗,精准医疗基因监测 |
| Procurement products： |
肿瘤检测,肿瘤基因检测,基因检测,精准医疗,精准医疗基因监测 |
| major business： |
|
|
